These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26613228)

  • 1. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
    Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
    Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistent central diabetes insipidus in a very low birth weight infant].
    Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
    Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
    Marín GR; Baspineiro B; Vilca I
    Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
    Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
    Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
    Thakore P; Dunbar AE; Lindsay EB
    J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
    Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
    Biset A; Claris O
    Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of central diabetes insipidus with oral desmopressin in a patient with ectrodactyly and cleft lip/palate (ECP) syndrome.
    Ozaydin E; Aycan Z; Yusufoğlu AM; Cetinkaya E; Ergen S; Unal S; Köse G
    Turk J Pediatr; 2009; 51(1):89-93. PubMed ID: 19378901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profound hypernatremia due to central diabetes insipidus.
    Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent central diabetes insipidus presenting in a very low birth weight infant successfully managed with intranasal dDAVP.
    Stapleton G; DiGeronimo RJ
    J Perinatol; 2000 Mar; 20(2):132-4. PubMed ID: 10785891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
    Almutlaq N; Eugster EA
    J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
    Smego AR; Backeljauw P; Gutmark-Little I
    J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Insipidus Presenting with Oligohydramnios and Polyuria During Pregnancy.
    Choi HS; Kim YH; Kim CS; Ma SK; Kim SW; Bae EH
    J Nippon Med Sch; 2018; 85(3):191-193. PubMed ID: 30135348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
    Fjellestad-Paulsen A; Crosnier H; Czernichow P
    Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay in desmopressin therapy: Disaster in waiting.
    Kroll C; Zandvakili A
    J Clin Pharm Ther; 2022 Dec; 47(12):2376-2378. PubMed ID: 36376238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus.
    Kamoi K
    Endocr J; 2013; 60(9):1115. PubMed ID: 23863202
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
    Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central diabetes insipidus following carbon monoxide poisoning.
    Chang MY; Lin JL
    Am J Nephrol; 2001; 21(2):145-9. PubMed ID: 11359023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyuria due to central diabetes insipidus presenting as an early manifestation of acute myeloid leukemia.
    Loukidis K; Papadakis E; Anagnostou N; Kiriklidou P; Gatsa E; Karagianni A; Patinakis P; Tsakiris D; Kioumi A; Korantzis I
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):399-400. PubMed ID: 22895244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Central diabetes insipidus: diagnosis and management].
    Ballan BK; Hernandez A; Rodriguez EG; Meyer P
    Rev Med Suisse; 2012 Nov; 8(362):2158, 2160-4. PubMed ID: 23240316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.